alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32.2**
   **Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
   **CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**
   In connection with the quarterly report of Rimpac Resources Ltd (the "Company") on Form 10-QSB for the period ended June 30, 2004 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Thomas M. Johnson, hereby certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:
  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  */s/ Thomas Johnson*


_______________________________


Thomas Johnson
**RIMPAC RESOURCES LTD**


President, Secretary, Treasurer and Director
October 28, 2004
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3717

ECM Industries LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
**EXHIBIT
31.2**
 **CERTIFICATION**
  I, Rose
C. Perri, certify that:
  1.
    
    I
      have reviewed this quarterly report on Form 10-Q of Generex
      Biotechnology Corporation;2.
    
    Based
      on my knowledge, this report does not contain any untrue statement of a
      material fact or omit to state a material fact necessary to make the
      statements made, in light of the circumstances under which such statements
      were made, not misleading with respect to the period covered by this
      report;3.
    
    Based
      on my knowledge, the financial statements, and other financial information
      included in this report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the
      registrant as of, and for, the periods presented in this
      report;4.
    
    The
      registrant's other certifying officer and I are responsible for
      establishing and maintaining disclosure controls and procedures (as
      defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the
      registrant and have:
 
 a)
    
    Designed
      such disclosure controls and procedures, or caused such disclosure
      controls and procedures to be designed under our supervision, to ensure
      that material information relating to the registrant, including its
      consolidated subsidiaries, is made known to us by others within those
      entities, particularly during the period in which this report is being
      prepared;b)
    
    Evaluated
      the effectiveness of the registrant's disclosure controls and procedures
      and presented in this report our conclusions about the effectiveness of
      the disclosure controls and procedures, as of the end of the period
      covered by this report based on such evaluation; andc)
    
    Disclosed
      in this report any change in the registrant's internal control over
      financial reporting that occurred during the registrant's most recent
      fiscal quarter that has materially affected, or is reasonably likely to
      materially affect, the registrant's internal control over financial
      reporting; and
 
 5.
    
    The
      registrant's other certifying officer and I have disclosed, based on our
      most recent evaluation of internal control over financial reporting, to
      the registrant's auditors and the audit committee of the registrant's
      board of directors (or persons performing the equivalent
      functions):
 
 a)
    
    All
      significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect the registrant's ability to record,
      process, summarize and report financial information;
andb)
    
    Any
      fraud, whether or not material, that involves management or other
      employees who have a significant role in the registrant's internal control
      over financial reporting.
 
 
 DATE: June 14, 2005By: /s/ Rose C. PerriRose C. Perri, Chief Operating
      Officer(Principal Financial and Accounting
      Officer)
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                         362,069
<SECURITIES>                                         0
<RECEIVABLES>                                   62,964
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               468,601
<PP&E>                                      23,534,879
<DEPRECIATION>                             (1,188,876)
<TOTAL-ASSETS>                              24,433,957
<CURRENT-LIABILITIES>                          861,089
<BONDS>                                      6,010,017
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  17,562,851
<TOTAL-LIABILITY-AND-EQUITY>                24,433,957
<SALES>                                              0
<TOTAL-REVENUES>                             1,900,180
<CGS>                                                0
<TOTAL-COSTS>                                2,256,408
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             625,591
<INCOME-PRETAX>                              (981,819)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (981,819)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (981,819)
<EPS-BASIC>                                     (0.10)
<EPS-DILUTED>                                   (0.10)


</TABLE>
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3673

ECM Industries LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
<PAGE>


EXHIBIT 10.1



                              FIRST AMENDMENT TO NOTE
                       BETWEEN COLLATERAL THERAPEUTICS, INC.
                       AND IMPERIAL BANK, DATED APRIL 4, 1998


The First Amendment ("Amendment") amends that certain note ("the Note") in the
original principal amount of $400,000 executed by Collateral Therapeutics, Inc.
("Maker") in favor of Imperial Bank ("Bank") as of September 14, 1998, as
follows:

1.   The dollar figure "$400,000.00" at the beginning of the Note and in the
first paragraph of the Note is hereby amended to read as "$1,000,000.00" in each
of the two places it appears.

2.   Except as provided above, the Agreement remains unchanged.

3.   This Amendment is effective as of September 14, 1998, and the parties
     hereby confirm that the Agreement as amended is in full force and effect.


COLLATERAL THERAPEUTICS, INC.
"BORROWER"

By:  /s/    Christopher J. Reinhard
            Christopher J. Reinhard
Title:      Chief Operating and Financial Officer

IMPERIAL BANK
"BANK"

By:  /s/    Tim Bubnack
Title:      Vice President
ex10f.htm







 


EX-10f


 


GREEN STAR ALTERNATIVE ENERGY, INC.


 


 


(a Nevada corporation)


 


 


ACTION OF THE


 


 


BOARD OF DIRECTORS


 


 


BY UNANIMOUS WRITTEN CONSENT


 


 


March 6, 2009


 


 


The undersigned, being all of the members of the Board of Directors of Green Star Alternative Energy, Inc., a Nevada corporation (the "Company"), do hereby take the following actions by unanimous written consent as of March 6, 2009 pursuant to §78.320 of the Nevada General Corporation Law and the provisions of the Company's By-laws which grant the authority to the Company's Board of Directors to adopt resolutions and actions by unanimous written consent in lieu of a meeting:


 


 


Approval of Promissory Note


 


 


WHEREAS: This Board of Directors acknowledges the receipt of $25,000 on March 6, 2009 as received from Jesse De Castro and this Board has reviewed the terms of that certain unsecured promissory note in the amount of $25,000 and payable to Jesse De Castro.


 


 


RESOLVED: This Board of Directors hereby authorizes and instructs the Company's officers to execute and deliver that certain unsecured promissory note in the amount of $25,000 and payable to Jesse De Castro.


 


 


General Authorization


 


 


RESOLVED: This Board of Directors hereby authorizes the Company's officers to take all other action that may be necessary or prudent to accomplish the authorizations and instructions set forth in the resolutions adopted in this Action.


 


 


Each of the following persons hereby affix their signature to this Action of the Board of Directors in their individual capacity as a Director of the Company.


 


 


Date: March 6, 2009


 



	  	  
	  /s/ Jesse De Castro	  	  /s/ Peter Gilcud
	
Jesse De Castro

	
Peter Gilcud







 







 



	
Green Star Alternative Energy Inc.


Board Action: March 6, 2009

	
 


1
EXHIBIT 32.1
**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THESARBANES-OXLEY ACT OF 2002**
In connection with the Quarterly Report of Payless ShoeSource, Inc. (the “Company”) on Form 10-Q/Afor the period ending May 1, 2004, as filed with the Securities and Exchange Commission on the datehereof (the “Report”), I, Steven J. Douglass, Chairman of the Board and Chief Executive Officer ofthe Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of theSarbanes-Oxley Act of 2002, that:
(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.
Date: June 7, 2005                                                              /s/  Steven J. Douglass   Steven J. Douglass   Chairman of the Board andChief Executive Officer(Principal Executive Officer)
|   | (1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|--------|--------------------------------------------------------------------------------------------------------------------------|

|   | (2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date: May 7, 2010 | /s/ Ronald S. Saks                                            |
|-------------------|---------------------------------------------------------------|
|              | Ronald S. Saks                                                |
|              | Chief Executive Officer(Principal Executive Officer)          |
|              |                                                          |
|              |                                                          |
| Date: May 7, 2010 | /s/ Lawrence E. Dickinson                                     |
|              | Lawrence E. Dickinson                                         |
|              | Vice President, Chief Financial Officer, and Secretary        |
|              | (Principal Financial Officer and PrincipalAccounting Officer) |
REAFFIRMATION OF VALIDITY GUARANTY


 


REAFFIRMATION OF VALIDITY GUARANTY, dated as of June 24, 2011, made by David J. Fremed (the “Guarantor”) in favor of Panta Distribution, LLC (“Panta”), in respect of the Validity Guaranty, as defined below.


 


RECITALS


 


WHEREAS, Zoo Publishing, Inc., a New Jersey corporation (the “Company”) is party to that certain Factoring and Security Agreement, dated as of September 9, 2011 (as amended, supplemented or otherwise modified, the “Factoring Agreement”), by and between the Company and Working Capital Solutions, Inc.


 


WHEREAS, pursuant to the Factoring Agreement, the Guarantor made that certain Validity Guaranty, dated as of September 9, 2011 (the “Validity Guaranty”), in favor of Working Capital Solutions, Inc.


 


WHEREAS, pursuant to that certain Limited Recourse Assignment, dated the date hereof, by Working Capital Solutions, Inc. to Panta (the “Limited Recourse Assignment”), Working Capital Solutions, Inc. assigned the Factoring Agreement and Validity Guaranty to Panta.


 


WHEREAS, immediately after the assignment of the Factoring Agreement and Validity Guaranty pursuant to the Limited Recourse Assignment, the Company and Panta amended and restated the Factoring Agreement as set forth in that certain Amended and Restated Factoring, Security and Purchase Order Financing Agreement, dated as of the date hereof, by and between the Company and Panta (the “Amended and Restated Factoring Agreement”).


 


WHEREAS, the Guarantor wishes to reaffirm that the provisions of the Validity Guaranty shall remain in full force and effect upon the effectiveness of the Amended and Restated Factoring Agreement and as otherwise provided herein;


 


WHEREAS, the Guarantor wishes to reaffirm the Validity Guaranty in favor of Panta.


 


NOW, THEREFORE, the Guarantor agrees as follows:


 


1.           The Guarantor hereby acknowledges receipt of the Amended and Restated Factoring Agreement and consents to the terms and execution thereof;


 


2.           The Guarantor hereby reaffirms all obligations to Panta pursuant to the terms of the Validity Guaranty and acknowledges that the guarantee contained in the Validity Guaranty is continuing and in full force and effect in favor of Panta.


 


3.           The Guarantor acknowledges that Panta may amend, restate, extend, renew or otherwise modify the Amended and Restated Factoring Agreement and any indebtedness or agreement of the Company, or enter into any agreement or extend additional or other credit accommodations, without notifying or obtaining the consent of the Guarantor and without impairing the liability of the Guarantor under the Validity Guaranty.


 



	
GUARANTOR:


	  
	
/s/ David J. Fremed


	
David J. Fremed, as an individual Guarantor
```

[Federal Register Volume 60, Number 50 (Wednesday, March 15, 1995)]
[Sunshine Act Meetings]
[Page 14057]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-6474]



                Sunshine Act Meetings



Federal Register / Vol. 60, No. 50 / Wednesday, March 15, 1995 / 
Sunshine Act Meetings
[[Page 14057]] 

Board of Governors of the Federal Reserve System

Time and Date: 11:00 a.m., Monday, March 20, 1995.

Place: Marriner S. Eccles Federal Reserve Board Building, C Street 
entrance between 20th and 2lst Streets, N.W., Washington, D.C. 20551.

Status: Closed.

Matters to be Considered:

    1. Personnel actions (appointments, promotions, assignments, 
reassignments, and salary actions) involving individual Federal 
Reserve System employees.
    2. Any items carried forward from a previously announced 
meeting.

Contact Person for More Information: Mr. Joseph R. Coyne, Assistant to 
the Board; (202) 452-3204. You may call (202) 452-3207, beginning at 
approximately 5 p.m. two business days before this meeting, for a 
recorded announcement of bank and bank holding company applications 
scheduled for the meeting.

    Dated: March 10, 1995.
Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95-6474 Filed 3-13-95; 10:23 am]

BILLING CODE 6210-01-P
```
#### IN RE OMNIBUS JUSTICE OF THE PEACE BILL

1919

RESOLUTION No. 34

RESOLUTION REQUESTING THE OPINION OF TIIE SUPREME COURT OF NORTH CAROLINA.

*Resolved by the Senate, the House of Representatives concurring:*

That the Supreme Court of North Carolina be requested, if it can conveniently and properly do so, to advise the General Assembly as to the Court’s interpretation of the recent amendments to the Constitution with especial reference to the question as to whether or not there is any provision in Article II, section 29, which would prohibit the General Assembly from enacting an omnibus justice of the peace bill.

Ratified this 26th day of February, A.D. 1919.

—Public Laws, 1919, p. 576.

MESSAGE FROM THE SUPREME COURT

*To the Honorable, the General Assembly of North Carolina:*

Pursuant to S. R. 812, H. R. 1005, the Court has conferred together as to the constitutionality of the proposed “Omnibus Bill” for the appointment of justices of the peace in the counties throughout the State, and are of the opinion that the bill is constitutional and not in contravention of the recent amendment, Article IT, section 29, which prohibits the enactment of any local, private or special act relating to the appointment of justices of the peace, etc., but authorizes general laws regulating this and other matters contained in the section referred to.

February 27th, 1919.

By the Court:

Walter Clakk, *Chief Justice.*

*—Senate Journal,*1919, p. 327;
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-1996

Brooks Instrument LLC:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
Exhibit 99.1

 

**Independent Accountant’s Report**

 

Merrill Lynch Municipal ABS, Inc. (as Depositor)

c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated

World Financial Center

North Tower, 9th Floor

250 Vesey Street

New York, New York 10080

 

Deutsche Bank Trust Company Americas (as Trustee)

60 Wall Street

New York, New York 10005

             

                                           Re:       Prerefunded Municipal Certificates Series 2            and Series 3 (the “Certificates”)

 

                                           Ladies and Gentlemen:

 

We have examined management’s assertions that the Depositor and            the Trustee have complied, in all material respects, with the provisions of the Trust            Agreement dated as of March 28, 1995 (the “Trust Agreement”), during the            periods covered by the annual report on Form 10-K filed by the Depositor on behalf of            the Trust for the fiscal year ended December 28, 2007 (the “Annual            Report”). Management is responsible for compliance with the Trust Agreement. Our            responsibility is to express an opinion on management’s assertions based on our            examination.

 

Our examination was made in accordance with standards established by the            American Institute of Certified Public Accountants and, accordingly, included            examining, on a test basis, evidence about the Depositor’s and the            Trustee’s compliance with the Trust Agreement and performing such other            procedures as considered necessary in the circumstances. We believe that our            examination provides a reasonable basis for our opinion.

 

In our opinion, the Depositor and the Trustee have complied, in all            material respects, with the Trust Agreement during the period covered by the Annual            Report and management’s assertions with respect to such compliance are fairly            stated, in all material respects, for the fiscal year ended December 28,            2007.

 

/**s**/ Aston Bell            CPA

 

New York, New York

March 17, 2008

 

 

 

 

----